|Bid||59.90 x 0|
|Ask||60.08 x 0|
|Day's Range||58.80 - 58.80|
|52 Week Range||45.50 - 65.80|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The deliberations are still in their preliminary stages, and DaVita may decide not to go through with a sale, the sources said on Wednesday, asking not to be identified because the matter is confidential. DaVita Medical Group could attract interest from a variety of bidders, including private equity firms and health insurers, the people said. DaVita did not immediately respond to a request for comment.
On a per-share basis, the Denver-based company said it had a loss of $1.14. Earnings, adjusted for non-recurring costs, came to 81 cents per share. The results fell short of Wall Street expectations. The ...
DaVita Healthcare Partners, one of the largest kidney care companies in the US, was the S&P 500's top gainer on October 16, 2017.
A handful of companies are using so-called last-mile programs to train new hires for as long as a year before taking them on as full-time members of the team.
The Denver-based company said it had net income of 65 cents per share. Earnings, adjusted for non-recurring costs, were 92 cents per share. The results beat Wall Street expectations. The average estimate ...
Jefferies in a note on Monday downgraded shares of Davita Inc (NYSE: DVA ), citing slowing treatment growth and a tight rate environment. DaVita is a kidney dialysis services company, operating through ...
Members of Congress are pushing to revise an Obama-era rule that barred some dialysis patients from getting aid from industry-backed charities, a change that could also make it easier for kidney care companies ...
The Denver-based company said it had net income of $2.29 per share. Earnings, adjusted for one-time gains and costs, were 79 cents per share. The results did not meet Wall Street expectations. The average ...
DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners, a unit within its medical group, has entered into a strategic partnership with Cigna, a global health insurance service company.
DaVita Inc. (DVA) reported fourth-quarter 2016 adjusted operating earnings of 98 cents per share that surpassed the Zacks Consensus Estimate of 91 cents.
The dialysis and kidney care company rode out a challenging year to finish ahead of the consensus estimates from analysts, but uncertainty regarding federal healthcare may make 2017 a crapshoot.
DaVita Inc reported a better-than-expected quarterly profit on Thursday as demand rose for its kidney care services. The results come amid growing controversy over attempts by the U.S. Department of Health and Human Services to prevent dialysis providers from using premium assistance from outside charities to steer patients into Obamacare individual insurance plans instead of Medicare or Medicaid to receive higher payments for medical services. Both DaVita and German rival Fresenius Medical Care received subpoenas from U.S. federal prosecutors last month investigating their ties with a charity that helps patients pay for kidney dialysis.
The Denver-based company said it had profit of 80 cents per share. Earnings, adjusted for one-time gains and costs, were 98 cents per share. The results topped Wall Street expectations. The average estimate ...
DaVita Inc reported on Thursday a 5.15 percent rise in quarterly revenue, boosted by its kidney care business. Net income attributable to the company was $157.7 million, or 80 cents per share, in the fourth ...
Health regulators warned that third-party financial help for insurance premiums to patients could drive up health costs and hurt insurers bottom lines.
A U.S. court has issued a preliminary injunction on a new federal rule that dialysis providers have said would prevent patients from using charitable assistance to buy private health insurance, Fresenius Medical Care (FMC) said on Thursday. The decision upholds a temporary hold on the rule and is a victory for dialysis providers FMC, DaVita Inc and U.S. Renal Care Inc, which had filed a lawsuit to block the rule. "The preliminary injunction is indefinite in duration and therefore will remain in effect as long as the court does not change it," FMC said.